Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Centene Community
NYSE:CNC Community
3
Narratives
written by author
0
Comments
on narratives written by author
63
Fair Values set
on narratives written by author
Create a narrative
Centene
Popular
Undervalued
Overvalued
Community Investing Ideas
Centene
AN
AnalystHighTarget
Consensus Narrative from 17 Analysts
Aging Demographics And Medicaid Expansion Will Drive Care Transformation
Key Takeaways Expansion in government health programs, strong contract wins, and favorable demographics are driving durable revenue growth across core and adjacent healthcare markets. Operational efficiencies, rate increases, and diversification into higher-margin health services are supporting improved margins and strengthening long-term profitability.
View narrative
US$91.50
FV
69.5% undervalued
intrinsic discount
10.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Centene
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Medicaid And Medicare Advantage Will Expand Health Care Access
Key Takeaways Medicaid business margin recovery and strong contract wins could enhance revenue growth and market share in government health programs. Improved Medicare Advantage outlook, alongside commercial segment growth, supports positive revenue and earnings prospects through operational efficiencies and increased membership.
View narrative
US$77.76
FV
64.1% undervalued
intrinsic discount
7.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
28
users have followed this narrative
4 days ago
author updated this narrative
Centene
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Expiring Premium Tax Credits And Medicaid Changes Will Constrain Performance
Key Takeaways Regulatory changes and competitive pressures threaten revenue stability, profitability, and enrollment growth across Centene’s core insurance markets. Rising medical and drug costs outpace government reimbursements, leading to sustained margin compression and increased financial risk.
View narrative
US$61.00
FV
54.2% undervalued
intrinsic discount
5.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
2 months ago
author updated this narrative
Your Valuation for
CNC
CNC
Centene
Your Fair Value
US$
Current Price
US$27.95
16.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
197b
2015
2018
2021
2024
2025
2027
2030
Revenue US$197.1b
Earnings US$4.4b
Advanced
Set Fair Value